
Journal of Medicinal Chemistry p. 3155 - 3160 (1990)
Update date:2022-09-26
Topics:
Hanson, Robert N.
Napolitano, Elio
Fiaschi, Rita
As part of our program to develop estrogenic radioligands for use in nuclear medicine, a study was undertaken to investigate the effect of substituents on the receptor affinity of putative radiochemicals.In the study a synthetic strategy directed toward the introduction of an 11β-(fluoroethyl) substituent was devised.The target compound 9 was prepared via a five-step procedure starting from 11β-vinylestrone 3-acetate (4) in an overall 43percent yield.The final product and several analogues, 11β-ethyl-, -vinyl-, and (hydroxyethyl)estradiols (11, 5, and 12), were evaluated for their estrogen receptor binding affinity.The results indicate that the target compound and several 11β-substituted analogues possess relative binding affinities greater than of estradiol and its 16α-fluorinated derivatives.The manner in which the target compound 9 was prepared is amenable to use with 18F incorporation.
View MoreTwin International Co., Limited
Contact:+86-21-80309280
Address:No.345 Jinxiang Road, Jinqiao Export Processing Zone
Suzhou Health Chemicals Co., Ltd.
website:http://www.healthchems.com
Contact:13776257979
Address:No. 338, Jingang Avenue,
Shijiazhuang Haitian Amino Acid Co., Ltd.
Contact:+86-311-88908111
Address:Shijiazhuang Hebei province,China
Nanjing Ruizhi Industry & Technologh Co.,Ltd.
Contact:+86-25-86808110
Address:441-4-A5,NO.12 Longzang Avenue,Yuhuatai District,210039,Nanjing
JIANGSU GRAND XINYI PHARMACEUTICAL CO.,LTD
website:http://www.xypharm.com/
Contact:+86-515-84383317
Address:Chenli Road,Costal Chemical Area Binhai,Yancheng, Jiangsu,China
Doi:10.1016/j.jorganchem.2010.08.056
(2011)Doi:10.1055/s-1989-27355
(1989)Doi:10.1016/j.bmc.2010.11.003
(2011)Doi:10.1016/S0040-4020(01)89209-7
(1989)Doi:10.1007/BF00479603
(1989)Doi:10.3987/COM-10-12090
(2011)